| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 02/08/2006 | CN1240691C Substituted penta azacylo compounds and their use for preventing and treating nervous retrogression disease |
| 02/07/2006 | US6995271 An intermediate to an antidiabetic compound, by reacting methyl (2-hydrocarbyl-5-methyloxazol-2-yl)acetate with sodium borohydride (NaBH4) using tetrahydrofuran as a solvent and methanol as activator; acetate becomes a 2-hydroxy ethyl group |
| 02/07/2006 | US6995181 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
| 02/07/2006 | CA2200433C Phenyloxazolidinone antimicrobials |
| 02/02/2006 | WO2006011466A1 5-substituted-2-phenylamino-benzamide as mek inhibitor |
| 02/02/2006 | WO2006010968A1 New aryloxy acetic acid amide derivatives |
| 02/02/2006 | US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/02/2006 | US20060025402 Benzimidazolidinone derivatives as muscarinic agents |
| 02/02/2006 | DE102004033021A1 Liquid pressure transmitting medium, useful in hydraulic component or machines, comprises ionic liquid as pressure transmitting medium |
| 02/01/2006 | EP1620440A1 Synthesis of substituted heterocyclic compounds |
| 02/01/2006 | EP1620434A1 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 02/01/2006 | EP1620420A2 Substituted carboxylic acids |
| 02/01/2006 | EP1620412A2 Heterocyclic compounds and hydro isomers thereof |
| 02/01/2006 | EP1620391A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 02/01/2006 | EP1620381A1 Hydroanthracene based compounds as anticancer agents |
| 02/01/2006 | EP1620093A2 Pesticidal (dihalopropenyl) phenylalkyl substituted benzoxazole and benzothiazole derivatives |
| 02/01/2006 | EP1620092A2 Compounds, compositions, and methods |
| 02/01/2006 | EP1620091A2 Inhibitors of glutaminyl cyclase |
| 02/01/2006 | EP1620086A1 Compounds that modulate ppar activity and methods of preparation |
| 02/01/2006 | EP1476419B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
| 02/01/2006 | EP1341774B1 Fused heteroaromatic glucokinase activators |
| 02/01/2006 | CN1727339A Tricyclic compounds, their production and use |
| 02/01/2006 | CN1239485C Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 01/31/2006 | US6992103 amidation and/or dehalogenation to form substituted [4-carbamoyl-2-hydroxypentyl]-benzamides; potent enzyme inhibitors of Asp2 [B-secretase, BACE1 (b-site Alzheimer's amyloid precursor protein cleaving enzyme) or Memapsin]; Alzheimer's disease |
| 01/31/2006 | US6992083 Benzoxazol derivatives |
| 01/31/2006 | CA2119261C Novel sidechain-bearing taxanes and intermediates thereof |
| 01/26/2006 | US20060019565 Method for delivering biologically active substnces |
| 01/26/2006 | US20060018825 Probe for diseases with amyloid accumulation, amyloid-staining agent, remedy and preventive for diseases with amyloid accumulation and diagnostic probe and staining agent for neurofibrillary change |
| 01/26/2006 | CA2574217A1 Diamine derivative, process of preparation thereof, and fungicide comprising diamine derivative as an active ingredient |
| 01/25/2006 | EP1618099A2 Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers |
| 01/25/2006 | EP1618087A2 Antibacterial agents |
| 01/25/2006 | EP1224189B1 Condensed dihydroquinolinone derivatives for inhibiting mrp1 |
| 01/25/2006 | CN1238354C Analog of nerve growth factor (2S, 4S)-2-(2'substituent)-4-(indole-3-methine)-5,5-disubstituent group-1, 3-f azole alkane compound, preparation method and application thereof |
| 01/25/2006 | CN1238347C Heterocyclic derivatives |
| 01/25/2006 | CN1238337C Pesticide |
| 01/24/2006 | USRE38947 Method of enantioselectively catalyzing a reaction |
| 01/24/2006 | US6989462 Synthesis of 2-chloromethyl-6-methylbenzoic ester |
| 01/19/2006 | US20060014836 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea;viricides; hepatitis virus |
| 01/19/2006 | US20060014830 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS |
| 01/19/2006 | US20060014781 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 01/19/2006 | US20060014743 Methods of preventing bacterial infections with florfenicol-type antibiotics |
| 01/18/2006 | EP1616865A1 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| 01/18/2006 | EP1615917A1 N-aryl-2-oxazolidinone-5-carboxamides derivatives with antibacterial activity |
| 01/18/2006 | EP1615899A1 Alpha-substituted carboxylic acids as ppar modulators |
| 01/18/2006 | EP1615636A1 Bicyclic compounds as nr2b receptor antagonists |
| 01/18/2006 | EP1435951B1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity |
| 01/18/2006 | EP1268096B1 Extrusion die |
| 01/18/2006 | EP1210327B1 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 01/18/2006 | CN1723207A Inhibitors of histone deacetylase |
| 01/18/2006 | CN1723204A Benzoxazole derivatives and their use as adenosine receptor ligands |
| 01/18/2006 | CN1237056C Oxazolidone compound, preparing method and use thereof |
| 01/17/2006 | US6987084 Photo-labile pro-fragrance conjugates |
| 01/17/2006 | CA2177171C Novel substituted oxazolidines |
| 01/12/2006 | WO2006003495A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 01/12/2006 | WO2005012270A3 Biaryl heterocyclic amines, amides, and sulfur-containing compounds and methods of making and using the same |
| 01/12/2006 | CA2573193A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 01/12/2006 | CA2572054A1 Crystalline form iv of linezolid |
| 01/11/2006 | EP1613587A2 Organic compounds |
| 01/11/2006 | EP1613326A1 (3-{3-´(2,4-bis-trifluormethyl-benzyl)-(5-ethyl-pyrimidin-2-yl)-amino!-propoxy}-phenyl)-acetic acid and related compounds as modulators of ppars and methods of treating metabolic disorders |
| 01/11/2006 | EP1613268A2 Methods for inhibition of angiogenesis |
| 01/11/2006 | CN1720252A Transition metal complex having diphosphine complex as ligand |
| 01/11/2006 | CN1235888C Preparation process of chlorazol thazone |
| 01/11/2006 | CN1235887C Preparation method of xazolyl alcohol derivatives |
| 01/11/2006 | CN1235870C Novel use of phenyl hetero alkylamine derivatives |
| 01/10/2006 | USRE38934 Method and reagents for N-alkylating ureides |
| 01/10/2006 | US6984653 useful as a growth factor receptor tyrosine kinase HER2 (Human epidermal growth factor receptor-2) inhibitor; for treating cancer |
| 01/10/2006 | US6984462 Organic electroluminescent devices using double-spiro organic compounds |
| 01/10/2006 | CA2129897C Coa-it and paf inhibitors |
| 01/05/2006 | WO2006000323A1 Novel hexafluoroisopropanol derivatives |
| 01/05/2006 | WO2005095364A8 Phenoxyacetic acid derivative and medicine containing the same |
| 01/05/2006 | WO2002046150A3 Compounds which mimic the chemical and biological properties of discodermolide |
| 01/05/2006 | US20060004093 obesity; antidiabetic agents; Alzheimer's disease; Huntington's disease;schizophrenia; anticancer agents; psoriasis; antiepileptic agents; strokes |
| 01/05/2006 | US20060004068 Novel hexafluoroisopropanol derivatives |
| 01/05/2006 | US20060004066 Method for treating ADAMTS-5-associated disease |
| 01/05/2006 | US20060004063 Inhibitors of HCV NS5B polymerase |
| 01/05/2006 | US20060004048 Novel biaromatic compounds which activate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/05/2006 | CA2571356A1 Novel hexafluoroisopropanol derivatives |
| 01/04/2006 | EP1612204A1 Hydrazone derivative |
| 01/04/2006 | EP1611120A1 Novel methods for the treatment of inflammatory diseases |
| 01/04/2006 | EP1611113A1 Process to produce enantiomerically enriched 1-aryl- and 1-heteroaryl-2-aminoethanols |
| 01/04/2006 | EP1611088A2 Hydroxamates as therapeutic agents |
| 01/04/2006 | EP1611083A1 Synthesis of 2-chloromethyl-6-methylbenzoic acid esters |
| 01/04/2006 | EP1610780A2 Cyclic protein tyrosine kinase inhibitors |
| 01/04/2006 | EP1363873A4 Peptide deformylase inhibitors |
| 01/04/2006 | EP1296979B1 HETeroARYL-SUBSTITUTED HETEROCYCLES and their use as pesticides |
| 01/04/2006 | CN1715273A Process for synthesizing benzoxazolinone compounds |
| 01/04/2006 | CN1234696C Taxad alkyl derivative and its prepn. process |
| 01/04/2006 | CN1234681C Amino acid derivatives and their use as pesticides |
| 01/03/2006 | US6982278 For modulating a peroxisome proliferator activated receptor, particularly in the treatment of diabetes mellitus |
| 12/29/2005 | WO2005123703A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 12/29/2005 | WO2005123702A1 Neutral endopeptidase inhibitor polymorph |
| 12/29/2005 | WO2005123050A2 Five-membered heterocycles useful as serine protease inhibitors |
| 12/29/2005 | WO2005099687A3 Analogs of salinosporamide a |
| 12/29/2005 | US20050288515 Chemical compounds |
| 12/29/2005 | US20050288343 Process of preparing substituted carbamates and intermediates thereof |
| 12/29/2005 | US20050288340 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 12/29/2005 | US20050288336 Cysteine protease inhibitors |
| 12/29/2005 | US20050288303 Cyclic protein tyrosine kinase inhibitors |
| 12/29/2005 | US20050288282 Anticancer agents; antiproliferative agents |
| 12/29/2005 | US20050288273 Antibacterial agents |